Nuwellis Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly2.4M
Gross Margin Quarterly7,010.0%
Cash and Cash Equivalents Quarterly2.2M
Watch Items
- Capital Sufficiency and Going Concern RiskTrigger: Cash runway falling below 1 quarter of operating expensesAction: Monitor warrant exercises and execute additional public offerings or private placements to sustain operations.
- CEO Transition ExecutionTrigger: Effective date of June 30, 2026Action: Track onboarding of incoming CEO Michael McCormick and alignment with commercial strategy.
- Aquadex SmartFlow Console PlacementsTrigger: Console sales dropping below 10 units per quarterAction: Re-evaluate direct sales team deployment and targeted critical care/pediatric account penetration.
Research as of 20 Jun 2026